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Abstract
Background: Anesthesia is indispensable for in vivo research but has the intrinsic potential to alter study results.
The aim of the current study was to investigate the impact of three common anesthesia protocols on physiological
parameters and outcome following the most common experimental model for subarachnoid hemorrhage (SAH),
endovascular perforation.
Methods: Sprague-Dawley rats (n = 38) were randomly assigned to (1) chloral hydrate, (2) isoflurane or (3)
midazolam/medetomidine/fentanyl (MMF) anesthesia. Arterial blood gases, intracranial pressure (ICP), mean arterial
blood pressure (MAP), cerebral perfusion pressure (CPP), and regional cerebral blood flow (rCBF) were monitored
before and for 3 hours after SAH. Brain water content, mortality and rate of secondary bleeding were also
evaluated.
Results: Under baseline conditions isoflurane anesthesia resulted in deterioration of respiratory parameters (arterial
pCO2 and pO2) and increased brain water content. After SAH, isoflurane and chloral hydrate were associated with
reduced MAP, incomplete recovery of post-hemorrhagic rCBF (23 ± 13% and 87 ± 18% of baseline, respectively)
and a high anesthesia-related mortality (17 and 50%, respectively). Anesthesia with MMF provided stable
hemodynamics (MAP between 100-110 mmHg), high post-hemorrhagic rCBF values, and a high rate of re-
bleedings (> 50%), a phenomenon often observed after SAH in humans.
Conclusion: Based on these findings we recommend anesthesia with MMF for the endovascular perforation model
of SAH.
Keywords: Subarachnoid hemorrhage, Rat, Experimental, Anesthesia, Isoflurane, Chloral hydrate, Medetomidine,
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Background
Experimental animal models are widely used to study the
pathophysiology of subarachnoid hemorrhage (SAH)
[1-4]. The induction of experimental SAH is performed
by invasive surgical techniques which require continuous
multimodal monitoring and adequate sedation and
analgesia. Ventilation and, hence, blood gases can be con-
trolled by intubation and mechanical ventilation [5],
however, other parameters which are known to critically
determine the outcome following experimental SAH
such as intracranial pressure (ICP), mean arterial blood
pressure (MAP) and regional cerebral blood flow (rCBF)
[1,2,6-9] may well be influenced by the applied anesthetic
protocol as already demonstrated for experimental mod-
els of cerebral ischemia [5] and traumatic brain injury
[10,11].
Various inhaled or injectable anesthetics have been used
in experimental SAH, e.g. halothane, isoflurane [alone or in
combination with nitrous oxide (N2O)] [1,3,4,12,13], chloral
hydrate, barbiturates [14-16], ketamine/xylazine or midazo-
lam/medetomedine/fentanyl (MMF) [17-19]. Although
experimental SAH models are known to suffer from some
variability [2,3,9], little is know to which degree the used
anesthetic protocol contributes to this phenomenon.
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any medium, provided the original work is properly cited.Therefore, we investigated the effect of three well estab-
lished and frequently used standard anesthesia protocols,
namely chloral hydrate, isoflurane, and MMF on animal
physiology, mortality and brain water content before and
after experimental SAH in rats. The ultimate aim of the
study was to determine how anesthesia influences the out-
come of experimental SAH and, if significant differences
are found between different anesthesia protocols, which
protocol has the least influence on the pathophysiology
induced by the endovascular perforation model, the most
frequently used and the presumably most clinically relevant
model of subarachnoid hemorrhage.
Methods
In this study we used 38 male Sprague-Dawley rats (250-
300 g body weight), purchased from Charles River Labora-
tories, Sulzfeld, Germany. Eight animals died during
experiments (see below), i.e. 30 animals were included in
the final analysis. Animals had free access to pellet food
until 12 hours prior to surgery. Water was accessible at all
time. All experiments were approved by the Ethics Com-
mittee of the District Government of Upper Bavaria,
Germany.
Anesthesia
Anesthesia protocols were chosen based on the frequency
of their use with the endovascular perforation model of
SAH (e.g. isoflurane), on their availability (e.g. halothane
was not included in the analysis since its production for
human use was discontinued resulting in a reduced avail-
ability for many laboratories), on their known small influ-
ence of cerebral blood flow (chloral hydrate and
midazolam/medetomidine/fentanyl), on the ease of their
termination (isoflurane and midazolam/medetomidine/
fentanyl), and on their level of standardization in experi-
mental and veterinary medicine (all three protocols).
Dose regiments were based on the scientific and veter-
inary literature and our own experience during the past 5
(midazolam/medetomidine/fentanyl) to 20 (chloral
hydrate and isoflurane) years. A similar level of sedation
between the three protocols was achieved by using the
lowest dose necessary to reach surgical anesthesia (as
verified by the tail pinch test and concomitant observa-
tion of withdrawal reflexes and systemic blood pressure).
Anesthesia was induced by placing animals in a cham-
ber with 4% isoflurane for 2-3 minutes. Thereafter rats
were randomized to one of the three standard anesthesia
protocols: (1) Chloral hydrate (1 ml/100 g body weight of
a 3.6% solution) was injected intraperitoneally (i.p.). Ani-
mals were intubated and ventilated with 70% air and 30%
O2 under control of ventilation pressure and rate (Small
animal ventilator KTR-4, Hugo Sachs Elektronik,
Germany). A third of the initial dosage was applied every
60 minutes in order to maintain anesthesia. (2) Animals
were ventilated with 2% isoflurane in 70% N2Oa n d3 0 %
O2. (3) Midazolam (2 mg/kg), medetomidine (0.15 mg/
kg) and fentanyl (0.0075 mg/kg) were given by intraperi-
toneal injection. Animals were ventilated with 70% air
and 30% O2. A third of the initial dosage was applied for
maintenance of anesthesia every 40 minutes. Atropine
(150 mg/kg bodyweight) was injected subcutaneously in
all experimental groups to inhibit salivary secretion and
induce bronchodilation.
Monitoring
The tail artery was canulated for continuous measure-
ment of mean arterial blood pressure (MAP) and for
blood sampling throughout the experiment. Arterial
blood gases, pH, serum glucose and lactate were analyzed
every 30 minutes. Ventilation rate (in ventilations per
minute = vpm) and pressure were adapted in order to
maintain physiological arterial pCO2 values (35-45
mmHg). Temporal muscle and rectal probes were used
to monitor brain and body temperature, respectively. A
thermostatically regulated, feedback-controlled heating
pad and lamp were used to maintain rectal and brain
temperature at 37°C.
Intracranial pressure (ICP) was continuously measured
using a Codman ICP microsensor (Johnson & Johnson
Medical Limited, Berkshire,U K ) .A f t e rd r i l l i n gab u r r
hole over the right parietal cortex under constant cool-
ing, the probe was advanced 2 mm into the brain and
fixed with dental cement. Cerebral perfusion pressure
(CPP) was calculated using the following formula: CPP =
MAP - ICP.
A 2-channel laser-Doppler flowmeter (LDF; MBF3D,
Moor Instruments Ltd.) was used for continuous monitor-
ing of regional cerebral blood flow (rCBF) in the territory
of the middle cerebral artery (MCA) of both hemispheres
as previously described [4,13].
Induction of SAH
SAH was induced by endovascular puncture, one of the
most widely used models for experimental SAH [1-3], as
previously described [4]. Briefly, a 3-0 monofilament was
advanced via the external carotid artery (ECA) into the
internal carotid artery (ICA) until increase of ICP and
bilateral decrease of rCBF indicated SAH. Subsequently,
the suture was withdrawn and the ECA ligated.
Experimental groups
In a first series of experiments blood gases, MAP, ICP,
CPP and rCBF were continuously monitored for 3 hours
under physiological conditions in all three experimental
groups (n = 5 each). Afterwards animals were sacrificed
for quantification of brain water content. In a second ser-
ies animals were randomly assigned to one of the three
anesthesia groups (n = 5 each) and SAH was induced. All
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conditions and continuously over 3 hours after SAH. At
the end of observation time anesthesia was terminated
and animals were tested for signs of awakening, i.e. ade-
quate spontaneous respiration. Animals that died during
surgery or exhibited excessive re-bleedings were replaced
u n t i lt h ef i n a lg r o u ps i z ew a sn=5i na l lg r o u p s .S u b s e -
quently, animals were re-anesthetized and sacrificed for
quantification of brain water content.
Quantification of brain water content
Brains were removed and the hemispheres were sepa-
r a t e da n dw e i g h e dt oa s s e s st h e i rw e tw e i g h t( W W ) .
Thereafter, the hemispheres were dried for 24 h at 110°C
and their dry weight (DW) was determined. Hemispheric
water content (%) was calculated using the following
formula: ((WW-DW)/WW) × 100.
Statistical analysis
Statistical analysis was performed with SigmaStat 3.1
(SPSS Science Inc., Chicago, IL, USA). Blood gas para-
meters were analyzed with Kruskal-Wallis - ANOVA on
ranks followed by Student-Newman-Keuls as post hoc
test, and for physiologic parameters ANOVA on ranks/
Dunn’s Method was applied. Two points in time of the
same group were compared with Friedman - repeated
measures ANOVA on ranks. Statistical significance of
results was assumed at p < 0.05 and a power of > 0.8.
Data are presented as means ± SEM if not otherwise
indicated.
Results
All three anesthesia protocols provided sufficient seda-
tion and analgesia for surgical intervention - the animals
showed no signs of untimely awakening or discomfort at
any time. Pinching of the hind paw did not trigger a
withdrawal reflex or an increase in blood pressure.
Ventilation rate and blood gases
Under physiological conditions anesthesia with isoflur-
ane required a significant increase of ventilation rate
during the 180 minutes of observation to keep PaCO2
within normal limits (58 ± 2 vpm vs. 27 ± 1 vpm in rat
anesthetized with MMF; p < 0.05; Table 1).
After SAH induction, anesthesia with isoflurane and
chloral hydrate required an increase of the ventilation
rate that reached statistical significance (p < 0.05) com-
pared to MMF after 180 minutes (47 ± 3, 42 ± 4, and
34 ± 3 vpm, respectively) (Table 1). Ventilation pressure
was not different between groups (12.6 ± 0.2, 12.7 ± 0.2
and 12.6 ± 0.4 cmH2Of o rc h l o r a lh y d r a t e ,i s o f l u r a n e
and MMF, respectively).
Arterial pCO2 and pH were not significantly different
between the three anesthesia protocols under physiological
conditions or after SAH induction. Arterial pO2 in the iso-
flurane group, however, decreased significantly during the
course of the experiment (p < 0.05) and was significantly
lower compared to chloral hydrate and MMF (p <0 . 0 5 )
after 60 and 180 minutes under physiological conditions
(116.0 ± 6.3, 89.6 ± 2.8, and 135.6 ± 8.8 mmHg for chloral
hydrate, isoflurane and MMF, respectively). Accordingly,
in SAH groups a decline in arterial pO2 was observed for
isoflurane (p < 0.05), with values significantly different
from the chloral hydrate and MMF group at 60 minutes
after SAH (Table 1).
ICP, MAP, CPP, and rCBF
There was no significant difference in ICP (values
around 5 mmHg) between the three groups under phy-
siological conditions. SAH resulted in an immediate
increase in ICP to a peak of 42 ± 8, 28 ± 4 and 61 ±
17 mmHg in the chloral hydrate, isoflurane and MMF
group, respectively (Figure 1A). This peak was followed
by a plateau of 15-20 mmHg that was reached after
15 minutes in all groups.
Under physiological conditions animals subjected to
MMF anesthesia exhibited a significantly (p < 0.05) higher
MAP (~100 mmHg) compared to the groups anesthetized
with chloral hydrate (~80 mmHg) or isoflurane (~70
mmHg). After SAH MAP remained significantly (p <0 . 0 5 )
elevated in the MMF group (Figure 1B). Of note, the sud-
den rise in ICP after SAH triggered a Cushing reflex in
MMF anesthetized animals: MAP acutely increased by
~20 mmHg (from 98 ± 7 to 118 ± 12 mmHg) and
returned to baseline values 15 minutes later. In animals
anesthetized with chloral hydrate or isoflurane, however,
this expected physiological increase in blood pressure was
not observed. On the contrary, MAP actually dropped
by 20 mmHg and recovered only slowly thereafter (Figure
1B) indicating that chloral hydrate and isoflurane interfere
with physiological blood pressure regulation.
Due to the higher MAP under physiological condi-
tions, CPP was significantly (p < 0.05) higher in MMF
anesthetized rats (~95 mmHg) compared to those ani-
mals which received chloral hydrate (~75 mmHg) or
isoflurane (~65 mmHg). Following SAH, CPP decreased
by ~30-45 mmHg in all experimental groups. In the
MMF group, CPP returned to near baseline values of 88
± 7 mmHg within 5 minutes after SAH. For chloral
hydrate and isoflurane a constantly reduced CPP was
observed after SAH (51 ± 7 and 41 ± 3 mmHg, respec-
tively; p < 0.05 vs. MMF).
Anesthesia with chloral hydrate or MMF did not
increase rCBF during the 3 hour observation time (7 ±
13% and 5 ± 6% rCBF increase vs. 30 min after initiation
of anesthesia, respectively), while in isoflurane anesthe-
tized rats rCBF increased by over 1/3 (35 ± 22% rCBF
increase vs. 30 min after initiation of anesthesia).
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lateral rCBF (p < 0.05) to ~10-30% of baseline (Figure 2).
No recovery was observed in the isoflurane group while
in MMF and chloral hydrate anesthetized rats rCBF
recovered to almost baseline values (92 ± 13% and 87 ±
18%, respectively). Contralateral rCBF recovered within
the 3 hours observation period in all groups.
Brain water content (BWC)
Following 4.5 hours of anesthesia, brain water content
was in the physiological range in the MMF group
(78.8 ± 0.1%) but increased in animals anesthetized
with chloral hydrate or isoflurane (p < 0.05; 79.5 ±
0.1% and 79.6 ± 0.1%, respectively; Figure 3) suggesting
either opening of the blood brain barrier or, more
likely, increasing cerebral blood volume due to
anesthesia-induced vasodilation.
Three hours after induction of SAH brain water con-
tent was 79.5 ± 0.2%, 80.1 ± 0.4%, and 78.9 ± 0.1% in
the chloral hydrate, isoflurane and MMF groups, respec-
tively. SAH did not result in an increase in brain water
content in chloral hydrate and MMF anesthetized ani-
mals (0% and 0.1% ΔBWC
pre/post), while slight brain
edema formation (0.5% ΔBWC
pre/post) was observed in
the isoflurane group (p < 0.05 vs. MMF; Figure 3).
Mortality and re-bleeding after SAH
There was no mortality during surgical preparation and
sham operated animals did not show any mortality.
After SAH, animals anesthetized with chloral hydrate
had the highest rate of intraoperative mortality (50%)
followed by animals anesthetized with MMF (29%) and
isoflurane (17%, Figure 4A).
Significant re-bleedings, which were identified by a
recurrent ICP increase of > 20 mmHg, were detected in
chloral hydrate (1/10, 10%) and MMF (4/7, 57%) anesthe-
tized animals, in the latter contributing to the mortality
in this group (Figure 4B). In total 8 out of the 38 animals
used for the current study died prematurely resulting in
n = 30 animals being included in the final analysis.
Discussion
In the present study we evaluated the effect of three widely
used and well standardized anesthesia protocols on patho-
physiology and outcome following subarachnoid hemor-
rhage (SAH) in rats. Surprisingly, different anesthesia
protocols resulted in completely different pathophysiolo-
gies following SAH. Isoflurane and chloral hydrate
anesthesia resulted in low blood pressure, lack of the
expected physiological post-ictal Cushing response,
impaired recovery of post-hemorrhagic ischemia and no
re-bleedings, while a combination of midazolam, medeto-
midine and fentanyl (MMF) maintained physiological
blood pressure, allowed the rising ICP to trigger the
expected increase in systemic blood pressure (Cushing
reflex), resulted in complete recovery of post-hemorrhagic
cerebral blood flow and caused a significant number of re-
bleedings, an important characteristic of SAH in humans.
Ventilation and arterial blood gases
Most agents used for small animal anesthesia cause a
dose dependent depression of central respiratory activity
Table 1 Physiological parameters during surgical preparation, before, and after SAH
physiological conditions after SAH
Preparation 0 min 60 min 180 min 0 min 60 min 180 min
Ventilation rate (v/min) chloral hydrate 36 ± 1 36 ± 2 46 ± 3* 47 ± 3* 37 ± 1 39 ± 2 42 ± 4*
isoflurane 35 ± 2 44 ± 4* 51 ± 2* 58 ± 2* 44 ± 2 43 ± 2 47 ± 3*
MMF 32 ± 2 30 ± 2 29 ± 2 27 ± 1 35 ± 3 35 ± 4 34 ± 3
Art. pCO2 (mmHg) chloral hydrate 36.9 ± 2.9 41.6 ± 2.8 41.8 ± 2.5 40.8 ± 3.4 40.5 ± 1.7 41.7 ± 2.2 43.2 ± 3.0
isoflurane 44.2 ± 1.9 45.1 ± 3.1 41.7 ± 4.0 42.9 ± 2.7 38.6 ± 0.8 44.1 ± 2.0 42.4 ± 2.9
MMF 40.3 ± 3.1 37.1 ± 1.2 34.5 ± 2.4 37.8 ± 3.3 41.7 ± 0.6 44.3 ± 2.3 43.3 ± 3.1
Art. pO2 (mmHg) chloral hydrate 136.6 ± 4.1 120.3 ± 3.4 116.0 ± 6.3# 113.1 ± 4.7# 125.1 ± 6.8# 116.5 ± 7.1# 109.6 ± 9.4
isoflurane 121.1 ± 4.2 105.1 ± 7.8 89.6 ± 2.8 86.4 ± 3.9 99.8 ± 5.3 92.3 ± 3.1 90.1 ± 5.6
MMF 125.6 ± 9.5 122.2 ± 9.7 135.6 ± 8.8# 135.4 ± 6.7# 105.2 ± 8.0 106.2 ± 6.9# 116.1 ± 9.5
pH chloral hydrate 7.29 ± 0.03 7.30 ± 0.02 7.29 ± 0.02 7.28 ± 0.03 7,34 ± 0,02 7.33 ± 0.01 7,28 ± 0,02
isoflurane 7.29 ± 0.02 7.32 ± 0.05 7.33 ± 0.04 7.35 ± 0.03 7,33 ± 0,01 7.29 ± 0.01 7,31 ± 0,03
MMF 7.34 ± 0.07 7.37 ± 0.01 7.35 ± 0.02 7.35 ± 0.01 7,37 ± 0,02 7.34 ± 0.04 7,35 ± 0,01
Glucose (mg/dl) chloral hydrate 196 ± 24 231 ± 20 169 ± 14 115 ± 16 186 ± 27 162 ± 23 138 ± 18
isoflurane 165 ± 20 158 ± 20 120 ± 10 114 ± 6 131 ± 15 121 ± 9 128 ± 8
MMF 196 ± 51 191 ± 37 156 ± 23 174 ± 26 208 ± 43 173 ± 17 181 ± 24
Lactate (mmol/l) chloral hydrate 1.0 ± 0.1 1.1 ± 0.1 0.8 ± 0.1 0.6 ± 0.1 1.2 ± 0.3 1.4 ± 0.3 0.7 ± 0.1
isoflurane 1.0 ± 0.1 1.3 ± 0.1 1.4 ± 0.2 1.5 ± 0.3 1.2 ± 0.3 0.8 ± 0.1 1.0 ± 0.0
MMF 0.5 ± 0.1 0.6 ± 0.0 0.7 ± 0.1 0.8 ± 0.2 0.6 ± 0.0 1.1 ± 0.1 0.8 ± 0.2
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Therefore, particularly with longer duration experi-
ments, intubation and mechanical ventilation is used to
keep blood gases within physiological limits [5]. Animals
in the isoflurane group experienced a gradual decrease
in arterial pO2 (blood oxygenation) and, similarly to
chloral hydrate, an increase in arterial pCO2 that
required continuous adjustments of ventilation para-
meters. Airway irritation and impaired mucocilliary
clearance have previously been described for inhalative
a g e n t sl i k ei s o f l u r a n ea n dh a l o t h a n e[ 2 2 , 2 3 ]a n dm o s t
probably account for the reduced gas exchange and
deterioration in blood gases. Keeping arterial paCO2
within physiological limits is particularly critical follow-
ing pathological conditions, as carbon dioxide is not
Figure 1 (A) Time course of ICP until 180 minutes after SAH.
No significant differences were observed between groups. (B) Time
course of dynamic MAP changes until 180 minutes after SAH. MAP
was significantly higher before and after SAH when animals were
anesthetized with MMF as compared to chloral hydrate or
isoflurane. SAH induced a Cushing response (transient increase of
MAP due to increased ICP) in animals anesthetized with MMF while
no such response was observed in the isoflurane or chloral hydrate
groups. ICP and MAP were recorded continuously, averaged over 3
minutes, and displayed as means ± SEM (n = 5 in each group; *p <
0.05 vs. isoflurane, #p < 0.05 vs. chloral hydrate; Kruskal-Wallis
ANOVA on ranks followed by Dunn’s post-hoc test).
Figure 2 Regional cerebral blood flow of the hemisphere
ipsilateral to hemorrhage measured by laser Doppler
fluxmetry until 180 minutes after SAH. SAH resulted in an
immediate reduction of rCBF in all groups with a significantly better
recovery in the MMF group (*p < 0.05 vs. isoflurane). rCBF was
recorded continuously, averaged over 3 minutes, and displayed as
percentage (%) of pre-hemorrhagic baseline (means ± SEM; n = 5 in
each group; Kruskal-Wallis ANOVA on ranks followed by Dunn’s
post-hoc test).
Figure 3 Brain water content (BWC) 3 hours following SAH or
in respective control animals. Streaked gray area indicates the
range of normal brain water content in animals not subjected to
long-term anesthesia. BWC is within the normal range under MMF
anesthesia while it is elevated in rats anesthetized with isoflurane (p
< 0.05) or chloral hydrate (Control). Following SAH BWC increased
only in animals anesthetized with isoflurane while it remained
unchanged in animals receiving chloral hydrate or MMF. Values are
presented as mean ± SEM for n = 5 in each group, *p < 0.05 vs.
isoflurane (Kruskal-Wallis ANOVA on ranks followed by Dunn’s
Method).
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hypercapnia and subsequent acidosis are known to
increase ischemic brain injury [25,26]. Also, hypoxemia,
a symptom of respiratory distress which is frequently
observed after SAH [27,28], has been shown to increase
the likelihood of a poor outcome [29-31]. In contrast to
isoflurane and chloral hydrate the MMF regimen did
not affect ventilation; pO2 and pCO2 remained in the
physiological range without necessitating constant
adjustment of ventilator settings. Therefore, in our
hands, MMF anesthesia provided the most stable phy-
siological conditions (especially in combination with
mechanical ventilation), allowing prolonged, hassle-free
surgery.
MAP, ICP, CPP, and rCBF
Anesthesia with chloral hydrate or isoflurane caused a
reduction of MAP, most likely due to their well known
negative effect on cardiac function and vascular tone
[20,32]. In contrast, MAP remained closest to physiolo-
gical values of conscious rats (100-110 mmHg) [33] in
the MMF group. The difference in MAP amongst the
groups correlated with the ICP increase during SAH
induction, which implies that the amount and severity
of hemorrhage in this model is directly influenced by
pre-hemorrhagic MAP. MAP monitoring is, therefore,
an absolute prerequisite for the proper and reproducible
induction of experimental SAH.
The acute stage of SAH is frequently accompanied by
derangements in arterial blood pressure [3,31,34]. A
hypertensive reaction, as exhibited in MMF animals, is
described as central activation of vasomotor centers to
restore cerebral perfusion in the presence of raised ICP,
i.e. the well known Cushing reflex [35,36]. The lack of
such a robust physiological reflex in the chloral hydrate
and isoflurane group suggests that these agents severely
affect the cardiovascular system, thereby altering post-
hemorrhagic pathophysiology in an uncontrolled man-
ner. Our data, therefore, indicate that studies on the
pathophysiology of SAH under chloral hydrate or iso-
flurane anesthesia may need to be re-interpreted care-
fully, since there is a high probability that they may
have been performed under a disturbed cardiovascular
baseline.
Even more divergent effects of the three anesthesia
protocols were observed when post-hemorrhagic rCBF
was measured. Whilst rats anesthetized with MMF
showed an almost complete recovery from SAH-induced
ischemia due to high MAP and CCP, rCBF did not
recover at all in animals receiving isoflurane anesthesia.
Since isoflurane and chloral hydrate have a very similar
suppressive effect on systemic blood pressure these find-
ings suggest that isoflurane may have an additional
vasodilatatory effect on cerebral vessels, as also sug-
gested by others [37]. The mechanisms responsible for
this effect seem to be a selective upregulation of nitric
oxide synthesis in the brain by volatile anesthetics [38].
These findings suggest that the use of isoflurane and
other volatile anesthetics should be discouraged when
studying SAH.
Brain water content
Our findings demonstrating increased brain water con-
tent in rats anesthetized with isoflurane are supported
by previous studies where volatile anesthetics increased
Figure 4 (A) Total number of operated rats per group stratified
by survival. The number of animals per group was increased until
n = 5 rats survived the 3 hour post-operative observation period.
Mortality in animals anesthetized with chloral hydrate, isoflurane, or
MMF was 50%, 17%, and 29%, respectively. (B) Number of animals
which suffered a re-bleeding following SAH stratified by animals
surviving (survivors) or not surviving (deaths) the post-operative
observation period of 3 hours. Numbers of animals which died from
anesthesia-induced complications are given in gray.
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These findings are in agreement with the local vasodila-
tatory effects of isoflurane on the cerebral vasculature;
vasodilation increases cerebral blood volume and hence
brain water content [40-42].
Isoflurane anesthesia increases brain water content fol-
lowing brain injury, e.g. after experimental traumatic
brain injury [11] and after focal cryogenic lesion [43] as
also observed in the current study. This is most likely
caused by the effect of isoflurane on cerebral blood
volume (see above), however, brain damage due to pro-
longed post-hemorrhagic ischemia/hypoperfusion [44]
w o u l da l s ob ee x p e c t e dt ob ei n v o l v e di nt h ed e v e l o p -
ment of brain edema in animals anesthetized with
isoflurane.
Mortality
The two major determinants of post-hemorrhagic mortal-
ity in our study were lack of recovery of cerebral hypoper-
fusion and re-bleeding. Interestingly, the occurrence of
hypoperfusion and re-bleeding depended exclusively on
the anesthetic protocol used. Hypoperfusion-/ischemic-
induced death only occurred after isoflurane and chloral
hydrate anesthesia. While isoflurane seems to have a direct
CBF-reducing effect (see above), chloral hydrate-induced
death was, in most cases, due to episodes of arterial hypo-
tension followed by cessation of rCBF following intraperi-
toneal re-application of chloral hydrate, as also reported in
experimental stroke [45]. This specific problem may, how-
ever, be overcome by continuous application of chloral
hydrate using a intraperitoneal catheter [46].
Mortality occurring in animals anesthetized with MMF
was, in all cases, related to post-hemorrhagic re-bleed-
ings, which are an integral part of the pathophysiology of
SAH in humans. The underlying mechanisms of MMF-
induced re-bleedings are the maintained MAP and CPP.
High MAP and CPP, although beneficial for cerebral per-
fusion, increase the risk for re-hemorrhages [47] with a
high mortality rate [48], as also suggested by our findings.
Hence, using MMF for anesthesia during experimental
SAH in rats reproduces an important component of SAH
in patient, i.e. delayed re-bleedings, which is usually miss-
ing when using when chloral hydrate or isoflurane.
Accordingly, only when rats were anesthetized with
MMF the pathophysiology of SAH was properly repro-
duced by the endovascular perforation model.
Handling for general anesthesia in rats
All three protocols proved to be suitable for surgical
anesthesia, however, only MMF appears to not have any
negative effect on the pulmonary system, thereby result-
ing in a far more stable maintenance of arterial pCO2
and pO2 with fewer interventions by the experimentalist
compared to isoflurane and chloral hydrate. When
considering that MMF anesthesia can be terminated by
injection of respective antagonists and that anesthesia
under chloral hydrate is difficult to judge and to termi-
nate [49], it seems fair to conclude that MMF is super-
ior to the other two investigated protocols.
Conclusion
We investigated if and how three widely used and well
standardized anesthesia protocols [isoflurane, chloral
hydrate, and a combination of midazolam, medetomi-
dine, and fentanyl (MMF)] affect pathophysiology and
outcome following experimental SAH in rats. Our
experiments demonstrate that when rats are anesthe-
tized with MMF key properties (re-bleedings, Cushing
reflex, moderate mortality) known to be integral parts of
the pathophysiology of SAH in humans [47,48,50] are
replicated by the endovascular perforation model of
experimental SAH. Our findings demonstrate that the
choice of anesthesia can have a significant impact on
animal models of disease and suggest that MMF should
be used for future studies using the endovascular per-
foration model of SAH.
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